BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37123562)

  • 1. Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
    Van Broeck D; Steelant B; Scadding G; Hellings PW
    Front Allergy; 2023; 4():1080951. PubMed ID: 37123562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study.
    Barroso B; Valverde-Monge M; Alobid I; Olaguibel JM; Rial MJ; Quirce S; Arismendi E; Barranco P; Betancor D; Bobolea I; Cárdaba B; Cruz Carmona MJ; Curto E; Domínguez-Ortega J; González-Barcala FJ; Martínez-Rivera C; Mahíllo-Fernández I; Muñoz X; Picado C; Plaza V; Rodrigo Muñoz JM; Soto-Retes L; Valero A; Del Pozo V; Mullol J; Sastre J
    J Investig Allergol Clin Immunol; 2023 Feb; 33(1):37-44. PubMed ID: 35416154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologics Reduce Symptoms of Alcohol Intolerance Better than Aspirin Desensitization in Patients with N-ERD and Nasal Polyps.
    Foerster-Ruhrmann U; Jurkov M; Szczepek AJ; Bergmann KC; Fluhr JW; Olze H
    Biomedicines; 2024 May; 12(5):. PubMed ID: 38790987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
    Mullol J; Laidlaw TM; Bachert C; Mannent LP; Canonica GW; Han JK; Maspero JF; Picado C; Daizadeh N; Ortiz B; Li Y; Ruddy M; Laws E; Amin N
    Allergy; 2022 Apr; 77(4):1231-1244. PubMed ID: 34459002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD.
    Tepetam FM; Özden Ş; Kılıç FK; Örçen C; Yakut T
    World Allergy Organ J; 2023 Sep; 16(9):100817. PubMed ID: 37771938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Discontinuation Rates of Peroral ASA Treatment for CRSwNP: A Real-World Multicenter Study of 171 N-ERD Patients.
    Laulajainen-Hongisto A; Turpeinen H; Vento SI; Numminen J; Sahlman J; Kauppi P; Virkkula P; Hytönen M; Toppila-Salmi S
    J Allergy Clin Immunol Pract; 2020; 8(10):3565-3574. PubMed ID: 32693216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline Conservative and Surgical Management in the Treatment of NSAID-Exacerbated Respiratory Disease.
    Sillanpää S; Numminen J
    Front Allergy; 2021; 2():659887. PubMed ID: 35387049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin desensitization following endoscopic sinus surgery is effective in patients with nonsteroidal antiinflammatory drug exacerbated respiratory disease.
    Aydin Ö; Atmiş EÖ; Anadolu Y; Yorulmaz İ; Çelik GE
    J Asthma; 2023 Jun; 60(6):1131-1140. PubMed ID: 36218308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal Anti-inflammatory Drug (NSAID) Tolerance After Biological Therapy in Patients With NSAID-Exacerbated Respiratory Disease: A Randomized Comparative Trial.
    Sánchez J; García E; Lopez JF; Calle A; Buendia JA
    J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2172-2179. PubMed ID: 37146885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab-Induced Aspirin Tolerance in Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease Patients Is Independent of Atopic Sensitization.
    Quint T; Dahm V; Ramazanova D; Arnoldner MA; Kurz H; Janik S; Brunner PM; Knerer-Schally B; Weninger W; Griss J; Ristl R; Schneider S; Bangert C
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):506-516.e6. PubMed ID: 34678497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of lower airway inflammation in patients with NSAID-exacerbated respiratory disease.
    Jakiela B; Soja J; Sladek K; Przybyszowski M; Plutecka H; Gielicz A; Rebane A; Bochenek G
    J Allergy Clin Immunol; 2021 Apr; 147(4):1269-1280. PubMed ID: 32810516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Options for Chronic Rhinosinusitis in N-ERD Patients.
    van der Lans RJL; Fokkens WJ; Reitsma S
    Front Allergy; 2021; 2():734000. PubMed ID: 35387032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease.
    Schneider S; Poglitsch K; Morgenstern C; Quint T; Gangl K; Sinz C; Bartosik T; Campion NJ; Liu DT; Landegger LD; Tu A; Stanek V; Rocha-Hasler M; Bangert C; Eckl-Dorna J
    Eur Respir J; 2023 Mar; 61(3):. PubMed ID: 36549708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis.
    Oykhman P; Paramo FA; Bousquet J; Kennedy DW; Brignardello-Petersen R; Chu DK
    J Allergy Clin Immunol; 2022 Apr; 149(4):1286-1295. PubMed ID: 34543652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD).
    Cousins K; Chen CC; Sehanobish E; Jerschow E
    Adv Pharmacol; 2023; 97():423-444. PubMed ID: 37236766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inheritance of NSAID-Exacerbated Respiratory Disease.
    Suikkila A; Lyly A; Hafrén L; Saarinen R; Klockars T
    Otolaryngol Head Neck Surg; 2023 Mar; 168(3):540-543. PubMed ID: 35639475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex, Ethnicity, Body Mass Index, and Environmental Exposures Associated With NSAID-Exacerbated Respiratory Disease Symptom Sequence.
    Dages KN; Sofola-James O; Sehanobish E; Regula P; Chen CC; Chiarella SE; Divekar RD; Cohen HW; Jerschow E
    J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3662-3669.e2. PubMed ID: 37541619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSAID-ERD Syndrome: the New Hope from Prevention, Early Diagnosis, and New Therapeutic Targets.
    Laidlaw TM; Levy JM
    Curr Allergy Asthma Rep; 2020 Mar; 20(4):10. PubMed ID: 32172365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
    Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversies in Allergy: Aspirin Desensitization or Biologics for Aspirin-Exacerbated Respiratory Disease-How to Choose.
    Laidlaw TM; Chu DK; Stevens WW; White AA
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1462-1467. PubMed ID: 34999274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.